A firmware bug in a medical device can become a patient harm event fast. In this guide, I’d boil the job down to 10 core moves: set security rules early, reduce memory bugs, validate every input, control access, lock debug ports, protect keys, verify boot and updates, cut exposed features, test hard, and track third-party code with an SBOM.

Here’s the short version:

  • Medical devices often stay in use for 5 to 10+ years, so patching and update design matter from day one.
  • Many devices include 80%+ third-party code, which means one weak library can affect many products at once.
  • Firmware security is tied to patient safety, not just data protection.
  • FDA rules now expect security work to be built into development, with traceability, testing records, and an SBOM.

If you work on medical firmware, these are the big things I’d focus on:

  1. Define security requirements and threat models early
  2. Use safer C/C++ patterns and memory controls
  3. Validate all inputs and fail in a safe way
  4. Apply strong authentication and role-based access control
  5. Disable or lock down debug and service ports
  6. Use current cryptography and protect device keys
  7. Enforce secure boot and signed updates
  8. Ship with locked-down defaults and less attack surface
  9. Run static analysis, code review, and fuzz testing
  10. Track third-party components and postmarket fixes

Bottom line: secure firmware work should map each risk to code, each code change to tests, and each release to records you can show later.

Focus area What I’d check first Why it matters
Design Threat model, safe-state rules, traceability Stops bad assumptions early
Code Memory handling, bounds checks, input validation Cuts common exploit paths
Access RBAC, session limits, service controls Reduces misuse of device functions
Trust Keys, signing, secure boot, update checks Helps stop tampered firmware
Maintenance SBOM, CVE review, patch process Helps handle long field life

The rest of the article turns those points into day-to-day coding and verification steps.

10 Secure Coding Best Practices for Medical Device Firmware

10 Secure Coding Best Practices for Medical Device Firmware

Top 10 Medical Device Vulnerabilities with Myles Kellerman | Ep. 38

Why Firmware Security Requires a Medical Device Mindset

Medical device firmware is safety-critical software. A coding flaw can change therapy, delay alarms, stop care, or damage clinical data. These incidents represent some of the biggest risks to patient care in modern health systems. That’s why the secure coding practices in this guide need a medical-device view from the start.

Safety-Critical Behavior Raises the Security Stakes

In many embedded systems, a security bug leads to data loss or downtime. In medical devices, that same kind of bug can change how the device behaves, delay a life-critical alarm, interrupt therapy, or corrupt clinical data - and those are direct patient safety issues [3].

There’s another wrinkle here. A security control can cause harm too. If it blocks emergency access at the wrong moment, it may be just as dangerous as having weak security in the first place [5]. So authentication has to match clinical use, not just security theory. That means audited emergency override paths for urgent care, with stronger authentication for configuration changes [1][2].

Long Device Life Cycles Create Maintenance Challenges

Medical devices often stay in service for 5 to 10 years or more [5][4]. That’s a long time in security terms.

Firmware built today may still be running long after its original security model starts to show its age. So patch planning, backward compatibility with legacy hospital systems, and secure update paths aren’t nice extras. They’re core design needs. Predictable, secure updates help cut patient risk and make field maintenance easier.

Constrained Hardware Limits Security Options

A lot of medical devices run on microcontrollers with tight limits on CPU, memory, storage, and power. Those limits shape what security controls you can use.

Heavy crypto, verbose logging, and some runtime protections may simply not fit the device budget [3]. The goal isn’t to copy desktop or server security and squeeze it in. It’s to use lean controls that fit the device and still do the job.

Clinical and Service Interfaces Expand the Attack Surface

Every interface on a medical device can become an entry point. That includes network connections, local wireless links, physical ports, and service tools.

Attack Surface Common Entry Points Security Control Requirement
Network Ethernet, Wi-Fi, Cloud APIs TLS 1.2/1.3, certificate pinning, mutual authentication
Local Wireless Bluetooth Low Energy (BLE) Authenticated pairing, encrypted profiles
Physical Ports USB, serial, JTAG/SWD Port lockdown, signed updates, tamper seals
Service Tools Maintenance ports, vendor apps Role-based access (RBAC), audit logging

These interface controls aren’t abstract checklist items. They tie straight into the coding practices covered next.

Validation and Change Control Are Stricter Than in General Embedded Software

IEC 62304 requires documented verification and traceability from identified hazards to code-level mitigations for every firmware change [3]. In plain terms, every patch needs regression testing and documented verification before release.

That changes the economics of firmware security. Fixing a mistake later is slower, heavier, and more expensive. Preventing defects before they ship matters a lot more here than it does in general embedded software.

With those constraints in view, the next 10 practices focus on stopping defects before they reach the field.

1. Define Security Requirements and Threat Models Early

If security requirements live only in someone’s head, they usually don’t make it into the firmware. That’s why this work needs to happen before coding starts. Spell out what the firmware must do and what it must never do.

A good way to do that is with STRIDE. Walk through each trust boundary, like device-to-network, sensor-to-processor, and service-port-to-cloud, and ask a simple question: what could an attacker do here? That process turns vague risk talk into specific checks engineers can build and test. You can pin down which inputs need range validation, which interfaces need authentication, and which failure cases need a defined safe state. From there, those requirements turn into code-level checks in the practices that follow.

Take an insulin pump as an example. If the dosage input has no type or range validation, that’s not just a coding mistake. It can become an overdose path. Set an allowlist for that input early, with the exact type, range, and format, and the control is built in from day one instead of bolted on later. And if authentication fails or validation breaks, the firmware should deny access or move into a defined safe state, not crash in some random way [1].

Regulatory Evidence Value

These same artifacts do double duty as verification evidence. FDA premarket guidance expects manufacturers to use a Secure Product Development Framework (SPDF) that is tied into design controls under 21 CFR 820.30 [2]. So don’t treat the threat model, security requirements, and traceability matrix as side documents. Make them part of the evidence chain for risk identification, implementation, and verification.

A traceability matrix should connect each identified hazard to:

  • a specific security requirement
  • the code module that handles it
  • the verification test that proves it works

That gives FDA reviewers the evidence trail they want to see [2][7].

Postmarket Maintainability

A threat model built at the start also pays off after release. When a new CVE shows up, you can check much faster whether the affected component or trust boundary exists in the firmware and how exposed it is in that setting. That baseline makes later vulnerability review faster and more exact.

2. Enforce Memory Safety and Safer C/C++ Coding Patterns

Once security rules are set, the next step is to enforce them in code with memory-safe patterns and compiler hardening.

C and C++ give developers direct control over memory. That's powerful, but it's also where bugs tend to show up. Memory safety failures are a major source of vulnerabilities in C/C++ embedded firmware [8]. In medical device firmware, a buffer overflow or use-after-free isn't just a software flaw. It can turn into a patient safety problem.

Patient Safety Impact

A memory bug can corrupt diagnostics, stop therapy, or crash the device. Treat every pointer, allocation, and string operation as safety-critical.

Firmware Exploit Reduction

Ban unsafe legacy APIs in the coding standard and enforce that rule in CI. Use bounded, length-checked functions with explicit size validation [1][9]. In real-time paths, lean on static allocation or fixed-size memory pools instead of heap allocation. That matters even more in ISRs and other timing-sensitive paths, where heap use should be avoided in favor of fixed-size pools [9].

In C++, RAII helps manage memory lifetime automatically and cuts use-after-free risk. Add a rule to zeroize freed memory and null pointers [9]. Then turn on compiler and hardware defenses where the platform supports them:

  • Stack canaries
  • Control-flow integrity (CFI)
  • NX/DEP
  • MPU isolation

If the hardware includes a Memory Protection Unit (MPU), use it to isolate components and enforce least-privilege access to memory regions [3][9].

Vulnerability Type C/C++ Prevention Practice Hardware/Compiler Mitigation
Buffer Overflow Bounded, length-checked functions; validate array bounds Stack canaries; MPU/MMU boundaries
Use-After-Free RAII; zeroize pointers on free; fixed-size pools Hardened allocators; guard pages
Integer Overflow Range checking; use safer math wrappers UndefinedBehaviorSanitizer (UBSan)
Null Dereference Static analysis (SAST); mandatory null checks MPU-protected zero-page

Regulatory Evidence Value

Keep static analysis reports, defect severity, and fix-or-justify decisions tied to commits [3][10]. Also keep machine-readable reports that show defect density, severity distribution, and time-to-remediation, mapped to specific code commits [3]. That's the paper trail reviewers want to see.

Postmarket Maintainability

Track repeat memory-safety defects by module so later releases can apply the same fix pattern in a steady way. Memory safety is just one layer. Every external input still needs strict validation before it reaches these code paths.

3. Validate Every Input and Fail Safely

A function can look perfect on paper and still cause harm if it accepts a bad sensor reading or a crafted network packet without checking it first. The rule is simple: never trust input from any source - not users, other systems, or sensors [1].

Patient Safety Impact

Right after memory-safe code, strict input validation at every boundary is the next big control. Bad input can lead to the wrong therapy, undefined behavior, or a device fault. That’s why every channel needs checks before data gets anywhere near clinical logic [1][3][5].

That includes:

  • network traffic
  • BLE
  • USB
  • DICOM/HL7 imports
  • touchscreens
  • service ports

Use allowlists, not denylists. In plain English, define what valid input is supposed to look like: accepted data types, value limits, and string patterns. If the input doesn’t match, reject it [1].

Firmware Exploit Reduction

When validation fails, the firmware must fail to a safe state. That means reject the input, log the failure, stop processing that input, and return a clear validation error [1]. No guessing. No trying to “make it work anyway.”

Fuzz testing helps here. Send malformed USB, BLE, and network data into external parsers and protocol handlers, then confirm the device doesn’t crash or drift into an unsafe state [3][5]. Input sanitization also needs to match the context [1]. A field that’s safe for display may not be safe for storage, parsing, or command handling.

Those malformed-input cases shouldn’t disappear after testing. They become part of the verification evidence.

Regulatory Evidence Value

This work also feeds the documentation trail regulators expect. FDA premarket documentation should link each input hazard to a software requirement, a test case, and a result [3][11]. Validation-failure logs also support postmarket monitoring and traceability [1][5].

4. Implement Strong Authentication and Role-Based Access Control

After input validation, the next control is authorization: who gets to issue, change, or approve a command? If authentication is weak, an attacker can take over before the device has any chance to protect the patient.

Patient Safety Impact

Not every user should have the same access. A nurse who starts or stops therapy should not have the same permissions as a biomedical technician who installs a firmware update. Role-Based Access Control (RBAC) keeps those lines clear by defining what each role can do - and just as important, what they can't do. Those rules should live in the firmware logic itself, not only in a cloud console or service tool.

Role Permissions Authentication Requirement
Clinical user Therapy changes, current settings MFA or equivalent strong authentication
Service user Diagnostics, updates, logs Time-limited privileged access
Patient Status viewing only Lowest required authentication level

Emergency override should be allowed only when it's clinically necessary, kept narrow in scope, and logged.

Firmware Exploit Reduction

Use a different credential for each device. Require credential changes on first use. Store secrets in hardware-backed protection, such as a Secure Element or a trusted execution environment like ARM TrustZone. Add session timeouts and rate limits after repeated failed login attempts. For device-to-device and device-to-cloud traffic, use mutual TLS (mTLS).

This is one of those areas where small gaps turn into big problems. If every device ships with the same password, or if admin sessions never expire, you've handed attackers an open door.

Regulatory Evidence Value

FDA premarket submissions need proof that access controls work in practice, not just on paper. That includes RBAC permission matrices, SAST results showing secrets are not hardcoded, and penetration test results aimed at authentication bypass and privilege escalation [1][5].

You should also log authentication attempts, authorization changes, and administrative actions in a tamper-evident way [1][5]. Those logs aren't just there for auditors. They're what teams rely on for postmarket forensics if something goes wrong in the field.

5. Lock Down Debug Ports and Apply Least Privilege

RBAC controls who can do what. Debug-port lockdown answers a different question: can someone reach the firmware at all?

Debug interfaces are for development, not production. JTAG, SWD, and UART should be disabled or fuse-locked at the hardware level before shipment. If debug ports, service modes, or local update paths stay open in production, they can sidestep software controls.

Patient Safety Impact

An open debug port is not just a data problem - it can become a patient safety problem. If an attacker can reach the bootloader through an unlocked debug interface, they may be able to replace it and bypass firmware signature verification before the device even starts [8]. And this doesn't take some fancy lab setup. A low-cost JTAG adapter can make physical compromise practical. On therapy-delivery devices, that can affect patient safety directly.

Firmware Exploit Reduction

Disable JTAG and SWD at the hardware level before shipment. Burning eFuses to lock these interfaces is irreversible by design [3]. That hard stop matters.

If an interface must stay active - say, a USB port for local firmware updates - lock it down with allowlists so the device accepts only specific commands or data types [1]. The idea is simple: allow only what is needed, block everything else.

For maintenance access, keep sessions time-limited and audited. Limit commands to the bare minimum needed for service. It also helps to provision a different key for each device during manufacturing, which helps prevent fleetwide exposure if one unit is compromised [8].

Regulatory Evidence Value

The FDA's 2023 cybersecurity guidance says premarket submissions should include clear evidence showing how service and debug interfaces are controlled [5]. In practice, that means things like fuse-state verification, service-mode penetration tests, and tamper-evident logs for debug-state changes and privileged maintenance actions [3].

The table below lines up well with what reviewers usually want to see:

Check Type Verification Method FDA Documentation Value
Debug Ports Physical inspection / Fuse verification Evidence of hardware-level attack surface reduction
Service Modes Logic testing / Exit criteria validation Demonstrates safety-critical isolation during maintenance
Privilege Access Penetration testing / Escalation attempts Proves role-based access control (RBAC) effectiveness
Logging Log integrity and coverage audits Supports postmarket forensic and audit requirements

Automated provisioning on the production line helps make this repeatable. Add audit checks that confirm eFuse states before a device ships, and you have a documented process instead of a one-off step [3].

After interface lockdown, the next move is protecting device keys and update trust.

6. Use Modern Cryptography Correctly and Protect Device Keys

Once ports are locked down, the next layer is the trust chain: how firmware is signed, stored, and checked before it runs.

In firmware, crypto problems usually come from bad implementation, not from picking the wrong algorithm. Old algorithms, hardcoded keys, and unencrypted flash storage open attack paths that should never exist in the first place. Put simply, key handling matters just as much as the math behind the crypto.

Patient Safety Impact

Cryptography helps keep therapy settings trustworthy. Without it, there is no solid way to confirm that the firmware running on a device - or the commands it receives - has not been changed. If keys are exposed, an attacker can alter code or commands and change device behavior in the field.

A real-world pacemaker recall showed how weak device security can force urgent firmware remediation across a large implanted fleet [5].

Firmware Exploit Reduction

Use cryptography to enforce trust, not just secrecy.

Use AES-128 or AES-256 for symmetric encryption, RSA-2048 or ECC P-256 for signing, and SHA-256 or SHA-3 for hashing. Drop MD5 and SHA-1 entirely - both are considered broken.

Cryptographic Category Recommended Avoid
Symmetric Encryption AES-128 or AES-256 DES, 3DES, RC4
Asymmetric / Signing RSA-2048 or ECC P-256 RSA below 2048 bits
Hashing SHA-256, SHA-3 MD5, SHA-1
Key Storage HSM, TPM, Secure Element Plaintext flash, hardcoded keys
Update Protocols TLS 1.2 or later with certificate pinning Unencrypted HTTP, FTP

Store signing keys in an HSM and device keys in a secure element or hardware root of trust so private keys never enter application memory. Give each device its own certificate during manufacturing. Never reuse one set of credentials across an entire fleet. Also, keep signing, telemetry, and TLS keys separate so one breach doesn't collapse every trust path [13].

Only signed firmware should run, no matter how the image gets onto the device.

Regulatory Evidence Value

FDA's 2023 premarket cybersecurity guidance requires manufacturers to document their encryption protocols and key management strategies as part of the Cybersecurity Management Plan [5]. That includes which algorithms are used, how keys are created and stored, and what the revocation path looks like if a key is exposed.

Postmarket Maintainability

Plan key rotation and revocation before launch so exposed keys can be replaced without putting the whole fleet at risk [13].

7. Secure Boot and Verified Firmware Updates

Secure boot and verified updates make sure only authenticated firmware can run. In practice, that means the signing keys and certificate controls set up earlier now carry through to startup and field updates. The chain breaks if any part skips verification, so the bootloader, update package, and transport layer all need to check trust before anything runs.

Patient Safety Impact

Life-critical logic, including dosing calculations and diagnostic outputs, lives in firmware. Secure boot makes sure only manufacturer-signed code runs from the moment the device powers on. If a signature or integrity check fails, the device must reject the image and fall back to the last known-good version or enter safe mode [5][1].

Firmware Exploit Reduction

Secure boot begins with an immutable hardware root of trust, such as boot ROM or OTP fuses, which verifies the first stage before execution [13]. Each image should be signed with the manufacturer key, and the device should verify both the image signature and hash before installation [13][6].

There’s another piece that matters a lot: anti-rollback. Update manifests need version numbers that the device checks against the installed version so attackers can’t load an older signed image that still has known flaws. Updates also need to be atomic, meaning the install either finishes fully or leaves the prior image untouched [13]. And the update channel itself should be protected with mTLS and per-device certificates [13].

Update Failure Mode Security Impact Mitigation
No anti-rollback Attacker installs older, vulnerable (but signed) firmware Enforce minimum-version checks on every install
Single signing key One leak compromises the entire device fleet Use separate, hardware-backed keys per function
No re-verification on boot In-place tampering after install goes undetected Bootloader must re-verify the image hash on every power cycle
Insecure update channel Man-in-the-middle attacks or unauthorized update access Implement mTLS with per-device certificates

Regulatory Evidence Value

Under Section 524B of the FD&C Act, the FDA expects manufacturers to keep a secure update path and include signed firmware and secure boot evidence in their cybersecurity documentation [14][15]. That means keeping architecture diagrams, adversarial test results, and controlled-build logs that show signing and verification happened inside a protected process. Those records also help with release decisions and with field response when update failures show up.

Postmarket Maintainability

Before launch, run the full update path with an inert payload over the production channel. It’s a simple test, but it shows whether the mechanism works under real conditions before a critical patch depends on it [13]. After launch, use staged rollouts: send the update to a pilot group first, watch for failures or safety issues, and then expand to the full fleet [5][4]. Once updates are trusted, the next step is shrinking the device’s exposed attack surface.

8. Reduce Attack Surface and Ship Secure Defaults

After secure boot and verified updates, the next step is to cut down what the firmware exposes by default.

If a device ships with every feature turned on, it also ships with extra risk. The job here is pretty plain: remove every entry point that isn't needed for clinical use, and lock down whatever stays on.

Patient Safety Impact

A UART port left open in production can hand an attacker a root shell. From there, they could change dosage settings or turn off alarms.

Firmware Exploit Reduction

Set secure defaults at build time. That means shipping with unique credentials for each device and turning off all nonessential interfaces.

On the hardware side, use eFuses to permanently disable JTAG, SWD, and UART before devices leave the factory [8][12]. On the network side, disable every protocol, port, and service that isn't needed for clinical use. Sensitive secrets, such as TLS certificates and API keys, should live in hardware-backed protection, like a secure element or trusted execution environment, not inside the firmware binary [8].

Attack Surface Layer Secure Default Action
Debug Interfaces Permanently disable JTAG/SWD/UART via eFuses before shipping
Credentials Unique per-device keys injected at manufacturing; no shared defaults
Network Services Disable all unused ports, protocols, and removable-media interfaces
Sensitive Secrets Store in hardware-backed protection, not in the firmware binary
Remote Access Off by default; enable only for time-limited, audited service sessions

Regulatory Evidence Value

FDA premarket guidance and Section 524B require manufacturers to provide a Software Bill of Materials (SBOM) and evidence of a Secure Product Development Framework (SPDF) [2][16]. Keep records that show which interfaces are disabled, how credentials are provisioned, and what the device's default network exposure looks like. In plain terms, that documentation should make the baseline easy to see: what is off, how secrets get loaded, and what is exposed on day one.

Postmarket Maintainability

Secure defaults also make life easier after launch. Fewer open interfaces mean fewer exposure points to watch and fewer settings for hospital IT teams to deal with. Clear hardening guides help too. If hospitals get direct guidance on required VLAN setups and communication port baselines, they're much more likely to keep the device in the security posture it was built for [4].

9. Integrate Static Analysis, Code Review, and Fuzz Testing

Once you've cut down the attack surface, the next step is simple: make sure the firmware itself can stand up to defects, logic mistakes, and bad input. A smaller attack surface helps, but it doesn't save you if the code still has flaws. And when firmware controls therapy, alarms, or device state, those flaws can turn into patient harm. That's why verification has to catch issues before release. No single method does that on its own.

Patient Safety Impact

Each method catches a different class of problem.

Static analysis finds defects before the code even runs. Manual review helps spot logic gaps and design mistakes that tools often miss. Fuzzing pushes malformed, random, and edge-case input through parsers and protocol handlers to see what breaks. In practice, fuzzing takes input validation a step further by pressure-testing those paths at scale.

These checks work best as one pipeline, not three separate checkpoints.

Firmware Exploit Reduction

Use a single workflow that brings all three together:

  • Run static analysis on every commit. Tools like Cppcheck or Coverity should be part of CI/CD [11][17].
  • Configure compilers with -Wall -Werror so warnings fail the build instead of getting ignored [18].
  • Block merges when there are new high-severity findings. If a finding can't be fixed right away, document it and give a formal justification [3].
  • Tie manual review to the code that matters most: safety logic, state transitions, and exception handling. Don't spend review time on syntax alone.
  • Run fuzz testing during integration against every external parser and interface [3][17].

That setup gives you early defect checks, human judgment where it matters, and runtime stress testing before software moves forward.

Regulatory Evidence Value

FDA premarket guidance and IEC 62304 both expect objective, documented proof of software verification [2][11]. So the work isn't just running the checks. It's keeping the records in a way that stands up later.

Keep:

  • Peer review records
  • Retained fuzz seeds and logs
  • Firmware hashes
  • Tool versions
  • Test results tied to the exact build that produced them [3]

That traceability matters. If a defect shows up, you should be able to reproduce it and connect it to a specific firmware version.

Each software safety requirement should also link to one or more test cases and the hazards those tests are meant to reduce. On top of that, perform Intended Use Validation (IUV) on all testing tools so you can show they produce reliable results for regulatory submissions [18].

Postmarket Maintainability

When a vulnerability report comes in, rerun the same test suite against the fielded build.

Static analysis helps catch defects early. Code review checks whether the code matches design intent. Fuzzing shows how the firmware behaves under hostile or malformed input. Together, they give you a tighter verification loop that is easier to repeat across releases and postmarket investigations.

Testing Method Primary Target SDLC Phase Regulatory Value
Static Analysis (SAST) Source code, logic, and syntax Implementation / CI Evidence of coding standard compliance (MISRA/CERT)
Manual Code Review Safety logic, state transitions, and exception handling Implementation Verification of safety-critical algorithms
Fuzz Testing Parsers, protocols, and inputs Integration / Testing Robustness evidence for external interfaces

10. Manage Third-Party Components, SBOMs, and Postmarket Fixes

After code review and fuzz testing, the next risk is simpler than it sounds: what goes into the build.

Modern medical device firmware leans on third-party code. That includes RTOSes, bootloaders, BSPs, middleware, and open-source libraries. And this isn’t a small issue. Between 70% and 90% of software vulnerabilities in medical devices sit in third-party components [5].

Patient Safety Impact

The Urgent/11 disclosure made the problem hard to ignore. A flaw in a shared TCP/IP stack left millions of devices open to remote code execution [5]. The core issue wasn’t just the use of third-party code. It was poor inventory and slow patching.

Firmware Exploit Reduction

The best defense starts with an accurate, machine-readable Software Bill of Materials (SBOM). That’s how teams avoid getting blindsided.

The FDA requires a machine-readable SBOM in CycloneDX or SPDX format, and it needs to come from production build artifacts, not developer workstations [5]. It also has to include transitive dependencies, not just direct ones. A flat dependency list won’t cut it. Use exact identifiers like pURLs or CPEs - for example, pkg:npm/lodash@4.17.19 - so the SBOM can be checked against the National Vulnerability Database (NVD) and CISA's Known Exploited Vulnerabilities (KEV) catalog [5].

Put SBOM generation inside the CI/CD pipeline with tools like Syft or the CycloneDX CLI so it refreshes with every firmware release. When SBOM creation happens at build time, dependency tracking becomes part of normal firmware work instead of a side chore for compliance.

It also helps to pair the SBOM with VEX (Vulnerability Exploitability eXchange) documentation. That gives teams a way to spell out which CVEs are actually exploitable in the device’s own context. Without that, vulnerability lists can get noisy fast. Reachability analysis can cut that noise by 60% to 80% [5].

Regulatory Evidence Value

FDA premarket submissions under Section 524B require SBOMs and Vulnerability Management Plans [5]. Reviewers want proof that the SBOM is a living document that gets updated with every release, not a one-and-done file made for an audit.

That means documenting:

  • the tools used to generate the SBOM
  • the versions of those tools
  • the response cadence for fixes: critical within 24–72 hours, high within 30 days, and medium within 90 days [5]

Postmarket Maintainability

After release, the work keeps going. Scan critical components daily and the full SBOM weekly against the NVD, CISA KEV, and vendor bulletins [5]. Any patch should pass regression and security testing, be signed, and include rollback.

Lifecycle tracking matters too. If a library is heading toward End-of-Life (EOL), that’s not just a paperwork detail. It can leave a device stuck with dependencies that can no longer be fixed, which makes postmarket support much harder [5].

Component inventory and fix tracking carry the same control into postmarket response.

Secure Coding Priorities at a Glance

To make the ten practices easier to use, the summary below pulls them into one quick reference. The table breaks each one down into the risk it cuts, the controls behind it, the mistakes that weaken it, and the proof that shows it was done.

Best Practice Primary Risk Mitigated Example Coding Controls Common Implementation Mistakes Evidence Artifacts
1. Early Requirements & Threat Modeling Missed attack vectors and design flaws STRIDE analysis; asset identification in SDLC Treating security as a final checkpoint; using generic models Threat model document; risk rating matrix
2. Memory Safety (C/C++) Buffer overflows; remote code execution Bounded copies; explicit bounds checks; memory-safe languages for new code Using unsafe unbounded C functions Static analysis (SAST) reports; defect density metrics
3. Input Validation & Safe Failure Injection attacks; system crashes Allowlists; type, range, and format checks Using denylists; trusting internal sensor data Fuzzing reports; unit test results
4. Authentication & RBAC Unauthorized access; privilege escalation MFA; unique per-device credentials Hardcoded or default passwords; shared accounts Penetration test findings; access logs
5. Debug Port Lockdown Physical tampering; firmware extraction Disabling JTAG/UART in production; fuse-locking Leaving debug ports active for "service convenience" Hardware configuration audits; physical pen-test reports
6. Modern Crypto & Key Protection Data breach; man-in-the-middle attacks AES-256; TLS 1.3; hardware-backed key storage "Rolling your own" crypto; hardcoding keys in source Crypto policy checks; key management audit logs
7. Secure Boot & Signed Updates Malicious firmware installation; downgrade attacks ECDSA signing; hardware root of trust; anti-rollback counters Unsigned updates; forgetting to enable secure boot fuses Firmware update validation logs; boot integrity logs
8. Attack Surface Reduction Remote service exploitation; lateral movement Disabling unused ports and services Shipping with all features enabled by default Vulnerability scan reports; port and service inventory
9. Static Analysis, Code Review & Fuzzing Logic flaws; hidden vulnerabilities SAST; peer review; coverage-guided fuzzing Ignoring "low" severity findings; no automated merge gating Code review sign-offs; fuzzing crash dumps; SAST reports
10. SBOM & Postmarket Fixes Supply chain attacks; unpatched dependencies Automated SBOM generation (SPDX/CycloneDX); continuous CVE monitoring Missing transitive dependencies; outdated SBOMs SBOM records; SCA scan results; patch logs

One pattern jumps out from the table: process gaps often open the door to the biggest risks. Open debug ports, weak SBOMs, and threat modeling done too late can undo a lot of careful coding. It’s the same old story - small misses upstream turn into big problems downstream.

And controls only go so far if nobody can prove they happened. Test logs, review sign-offs, and SBOM records turn a security step from a claim into something teams can point to and defend. For firmware, that paper trail matters because security work isn’t done when a control exists on paper. It has to be documented, tested, and traceable.

How These Practices Support U.S. Regulatory and Risk Management Requirements

These practices line up directly with FDA cybersecurity and quality-system documentation. The upside is simple: you can use the same evidence to show design control, verification, and postmarket readiness.

Map Secure Coding Controls to FDA Cybersecurity Documentation

Each practice leads to a clear FDA-ready artifact. Threat models and security requirements from Practice 1 support design-phase evidence. Static analysis, code review, and fuzz testing outputs from Practice 9 support premarket verification records. Secure boot and signed update logs from Practice 7 support postmarket management plan documentation. FDA expects traceability from requirement to code to test [2].

Secure Coding Practice Primary Evidence Artifact
Threat models, security requirements Security Risk Management evidence
SAST logs, code review checklists Verification and Validation records
Cryptography records that cite FIPS 140-2/3 validation Cybersecurity Controls / FIPS compliance
Secure boot and update validation logs Postmarket Management Plan
SBOM in SPDX or CycloneDX format Section 524B requirements

Build Evidence for Verification and Secure Development

Use CERT C/C++ and MISRA C as review baselines. Cryptography records that cite FIPS 140-2/3 validation, secure boot verification logs, and fuzz testing results all add to a verification package reviewers can assess [5].

This is where teams often trip up. The work may be done, but the proof is scattered across tools, tickets, and test systems. Pulling those records together makes the review process far less painful.

Connect SBOM and Component Tracking to Vulnerability Management

For firmware, supply-chain inventory is part of the security evidence. It isn't a separate side task. Since third-party components are common, the SBOM becomes the main inventory control.

Section 524B requires a machine-readable SBOM in SPDX or CycloneDX format [19]. Teams should also scan the SBOM against CVE sources on a continuous basis and document compensating controls for any vulnerability that can't be patched right away [14].

Automated Software Composition Analysis (SCA) in the CI/CD pipeline helps keep the SBOM current. That turns it into a living document instead of a stale snapshot sitting between releases [5].

Documentation should show more than what might fail. It should also show what that failure means for patients by identifying critical security risks.

A cybersecurity issue can delay diagnosis, interrupt therapy, or lead to patient harm. That's why FDA expects cybersecurity risk analysis to be tied to safety risk management for both premarket submissions and postmarket monitoring [19].

Centralize Fleet and Vendor Evidence for Day-to-Day Use

Day-to-day operations get messy fast if evidence lives in five different places. Platforms like Censinet RiskOps™ centralize SBOMs, risk assessments, and remediation records across connected device fleets, which helps keep firmware, vendor, and remediation records usable after release [19].

Conclusion

Secure coding in medical device firmware isn't a one-time task. It runs from early design all the way through postmarket monitoring. In plain terms, secure coding is part of patient-safety engineering.

Taken together, these 10 practices create a baseline secure-coding program: threat modeling, memory safety, input validation, authentication, debug port controls, cryptography, secure boot, attack surface reduction, testing, and supply chain management. These are baseline controls, not advanced measures. They help teams cut exploitable weaknesses before a device reaches a patient.

These failures show why compliance matters, but patient safety is the real goal.

Teams should treat these practices as living controls across the device life cycle. A delayed patch can become a patient risk. In medical devices, secure code is safe care.

FAQs

How do we balance security with emergency clinical access?

Balance security with emergency clinical access by following the FDA’s hierarchy: put patient safety and device function first, ahead of cybersecurity controls.

Use tiered authentication based on urgency. For routine checks, a password may be enough. In an emergency, an override can use biometric authentication so clinicians can get in fast, with the event logged and audited.

The key is to design and document these workflows early. If you wait too long, security can get in the way of patient care - and that’s the last thing anyone wants in a clinical setting.

What should a medical device SBOM include?

A medical device SBOM should give you a complete, machine-readable inventory of all third-party, open-source, and proprietary software components.

That inventory should include supplier names, component names, versions, unique identifiers, dependency relationships, the SBOM author, and a generation timestamp.

Manufacturers should also document:

  • Integration points
  • Component hierarchy
  • Known vulnerabilities
  • Security update availability
  • End-of-life status
  • Linked device models
  • Build timestamps
  • Component hashes

Which firmware security controls should teams implement first?

Teams should start with a secure-by-design approach and build security into the product from the earliest development phase. Security works best when it isn't bolted on at the end.

It's also important to keep a complete inventory of what you're shipping. An SBOM helps teams identify components and map known vulnerabilities, which makes it much easier to see where risk may be hiding.

A few baseline controls matter right away:

  • Secure boot with a hardware-backed root of trust
  • Rigorous input validation
  • Cryptographic signing for all updates to protect integrity and prevent tampering

These controls help make sure devices start in a known-good state, handle data safely, and accept only trusted updates.

Related Blog Posts